The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 22, 2022

Filed:

Sep. 06, 2018
Applicant:

The Trustees of the University of Pennsylvania, Philadelphia, PA (US);

Inventors:

Michael Farwell, Wynnewood, PA (US);

Mark Sellmyer, Philadelphia, PA (US);

Katheryn M. Lohith, Lansdale, PA (US);

Assignee:
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 51/04 (2006.01); A61K 35/17 (2015.01); A61K 31/506 (2006.01); A61K 38/17 (2006.01); C12N 9/22 (2006.01); C12N 9/06 (2006.01); G01N 33/50 (2006.01); C12N 15/85 (2006.01);
U.S. Cl.
CPC ...
A61K 51/0459 (2013.01); A61K 31/506 (2013.01); A61K 35/17 (2013.01); A61K 38/1774 (2013.01); A61K 51/0463 (2013.01); C12N 9/003 (2013.01); C12N 9/22 (2013.01); C12N 15/85 (2013.01); C12Y 105/01003 (2013.01); G01N 33/505 (2013.01); C12N 2800/80 (2013.01);
Abstract

The present invention includes an engineered cell comprising a chimeric antigen receptor (CAR) further comprising a nucleic acid molecule comprising a suicide gene comprising a ligand binding domain and a suicide domain wherein the ligand binding domain is capable of binding to radiolabeled tracer or a small molecule suicide switch. This invention also includes methods for inducing apoptosis of an engineered cell, methods for assessing the efficacy or toxicity of an adoptive cell therapy in a subject, methods for detecting the quantity of engineered T cells in a subject, methods for monitoring an immunotherapy treatment in a subject and methods of imaging engineered T cells in a subject. In some embodiments, the imaging is performed via Positron Emission Topography (PET). This invention further includes a chemical inducer of dimerization (CID), wherein the CID is a Bis-Trimethoprim (Bis-TMP).


Find Patent Forward Citations

Loading…